肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

美国COVID-19大流行期间乳腺癌患者的经济负担研究

Financial Toxicity among Patients with Breast Cancer during the COVID-19 Pandemic in the United States

原文发布日期:21 December 2023

DOI: 10.3390/cancers16010062

类型: Article

开放获取: 是

 

英文摘要:

This study reported the prevalence of financial distress (financial toxicity (FT)) and COVID-19-related economic stress in patients with breast cancer (BC). Patients with BC were recruited from the Ciitizen platform, Breastcancer.org, and patient advocacy groups between 30 March and 6 July 2021. FT was assessed with the COmprehensive Score for financial Toxicity (COST) instrument. COVID-19-related economic stress was assessed with the COVID-19 Stress Scale. Among the 669 patients, the mean age was 51.6 years; 9.4% reported a COVID-19 diagnosis. The prevalence rates of mild and moderate/severe FT were 36.8% and 22.4%, respectively. FT was more prevalent in patients with metastatic versus early BC (p< 0.001). The factors associated with FT included income ≤ USD 49,999 (adjusted odds ratio (adj OR) 6.271,p< 0.0001) and USD 50,000–USD 149,999 (adj OR 2.722,p< 0.0001); aged <50 years (adj OR 3.061,p= 0.0012) and 50–64 years (adj OR 3.444,p= 0.0002); living alone (adj OR 1.603,p= 0.0476); and greater depression severity (adj OR 1.155,p< 0.0001). Black patients (adj OR 2.165,p= 0.0133), patients with income ≤ USD 49,999 (adj OR 1.921,p= 0.0432), or greater depression severity (adj OR 1.090,p< 0.0001) were more likely to experience COVID-19-related economic stress. FT was common in patients with BC, particularly metastatic disease, during COVID-19. Multiple factors, especially lower income and greater depression severity were associated with financial difficulties during COVID-19.

 

摘要翻译: 

本研究旨在报告乳腺癌患者中财务困境(财务毒性)及与COVID-19相关的经济压力的普遍性。研究于2021年3月30日至7月6日期间,通过Ciitizen平台、Breastcancer.org及患者倡导团体招募乳腺癌患者。财务毒性采用综合财务毒性评分量表进行评估,COVID-19相关经济压力则通过COVID-19压力量表进行测量。在669名患者中,平均年龄为51.6岁;9.4%的患者报告确诊COVID-19。轻度及中度/重度财务毒性的患病率分别为36.8%和22.4%。与早期乳腺癌患者相比,转移性乳腺癌患者的财务毒性更为普遍(p<0.001)。与财务毒性相关的因素包括:年收入≤49,999美元(调整后比值比6.271,p<0.0001)及50,000–149,999美元(调整后比值比2.722,p<0.0001);年龄<50岁(调整后比值比3.061,p=0.0012)及50–64岁(调整后比值比3.444,p=0.0002);独居(调整后比值比1.603,p=0.0476);以及更严重的抑郁症状(调整后比值比1.155,p<0.0001)。黑人患者(调整后比值比2.165,p=0.0133)、年收入≤49,999美元的患者(调整后比值比1.921,p=0.0432)或抑郁症状更严重的患者(调整后比值比1.090,p<0.0001)更可能经历COVID-19相关的经济压力。在COVID-19疫情期间,财务毒性在乳腺癌患者中较为常见,尤其是转移性疾病患者。多种因素,特别是较低收入和更严重的抑郁症状,与疫情期间的财务困难相关。

 

原文链接:

Financial Toxicity among Patients with Breast Cancer during the COVID-19 Pandemic in the United States

广告
广告加载中...